Abstract
A Philadelphia chromosome-negative (Ph(-)) clone with trisomy X appeared in the bone marrow cells from a patient with Ph(+) chronic myelocytic leukemia in the chronic phase after hydroxyurea and interferon-alpha treatment.
MeSH terms
-
Adult
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Chromosomes, Human, X*
-
Clone Cells / pathology
-
Disease Progression
-
Female
-
Humans
-
Hydroxyurea / adverse effects
-
Hydroxyurea / therapeutic use
-
Interferon-alpha / adverse effects
-
Interferon-alpha / therapeutic use
-
Karyotyping
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Trisomy*
Substances
-
Antineoplastic Agents
-
Interferon-alpha
-
Hydroxyurea